Trial Outcomes & Findings for TRUST: Lumos-T Safely RedUceS RouTine Office Device Follow-up (NCT NCT00336284)

NCT ID: NCT00336284

Last Updated: 2010-08-03

Results Overview

Average number of office-based implantable cardioverter defibrillator (ICD) follow-up visits in the Home Monitoring arm vs the Conventional (calendar-based) follow-up arm.

Recruitment status

COMPLETED

Study phase

PHASE4

Target enrollment

1450 participants

Primary outcome timeframe

12 months

Results posted on

2010-08-03

Participant Flow

Participant milestones

Participant milestones
Measure
Home Monitoring
Home Monitoring programmed ON
Conventional
Home Monitoring programmed OFF
Overall Study
STARTED
977
473
Overall Study
COMPLETED
741
322
Overall Study
NOT COMPLETED
236
151

Reasons for withdrawal

Reasons for withdrawal
Measure
Home Monitoring
Home Monitoring programmed ON
Conventional
Home Monitoring programmed OFF
Overall Study
Death
52
26
Overall Study
Lost to Follow-up
82
61
Overall Study
Withdrawal by Physician or Subject
102
64

Baseline Characteristics

TRUST: Lumos-T Safely RedUceS RouTine Office Device Follow-up

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Home Monitoring
n=908 Participants
Home Monitoring programmed ON
Conventional
n=431 Participants
Home Monitoring programmed OFF
Total
n=1339 Participants
Total of all reporting groups
Age Continuous
63 years
STANDARD_DEVIATION 13 • n=5 Participants
64 years
STANDARD_DEVIATION 12 • n=7 Participants
64 years
STANDARD_DEVIATION 13 • n=5 Participants
Sex: Female, Male
Female
254 Participants
n=5 Participants
116 Participants
n=7 Participants
370 Participants
n=5 Participants
Sex: Female, Male
Male
654 Participants
n=5 Participants
315 Participants
n=7 Participants
969 Participants
n=5 Participants
Region of Enrollment
United States
896 participants
n=5 Participants
425 participants
n=7 Participants
1321 participants
n=5 Participants
Region of Enrollment
Canada
12 participants
n=5 Participants
6 participants
n=7 Participants
18 participants
n=5 Participants

PRIMARY outcome

Timeframe: 12 months

Population: Only participants who completed at least one follow-up visit are included in the analyses.

Average number of office-based implantable cardioverter defibrillator (ICD) follow-up visits in the Home Monitoring arm vs the Conventional (calendar-based) follow-up arm.

Outcome measures

Outcome measures
Measure
Home Monitoring
n=908 Participants
Home Monitoring programmed ON
Conventional
n=431 Participants
Home Monitoring programmed OFF
Home Monitoring Effectiveness
2.1 In-office ICD follow-up per patient year
Interval 0.0 to 45.6
3.8 In-office ICD follow-up per patient year
Interval 0.0 to 19.2

PRIMARY outcome

Timeframe: 12 months

Population: Safety Event Rate includes events occuring within 12 months of enrollment for participants with at least 1 follow-up.

Percentage of participants experiencing death, incidence of stroke, or event(s) requiring surgical intervention. Outcome measure time frame is 12 months.

Outcome measures

Outcome measures
Measure
Home Monitoring
n=908 Participants
Home Monitoring programmed ON
Conventional
n=431 Participants
Home Monitoring programmed OFF
Percent of Participants Experiencing Death, Incidence of Stroke, or Event Requiring Surgical Intervention.
10.4 Percentage of participants
10.4 Percentage of participants

SECONDARY outcome

Timeframe: 12 months

Population: Only participants with at least one follow-up are included in the analyses.

Detection time relative to onset of cardiac events (atrial fibrillation, ventricular tachycardia, ventricular fibrillation).

Outcome measures

Outcome measures
Measure
Home Monitoring
n=908 Participants
Home Monitoring programmed ON
Conventional
n=431 Participants
Home Monitoring programmed OFF
Early Detection of Cardiac Events
13.98 Days
Interval 0.0 to 256.0
45.34 Days
Interval 0.0 to 287.0

SECONDARY outcome

Timeframe: 12 months

Population: Only participants with at least one follow-up are included in the analyses

Percentage of total patient initiated inqueries that result in ER or office follow-up visits.

Outcome measures

Outcome measures
Measure
Home Monitoring
n=908 Participants
Home Monitoring programmed ON
Conventional
n=431 Participants
Home Monitoring programmed OFF
Patient Initiated Follow-up
92.7 percent of patient initiated follow-ups
100 percent of patient initiated follow-ups

Adverse Events

Home Monitoring

Serious events: 124 serious events
Other events: 0 other events
Deaths: 0 deaths

Conventional

Serious events: 74 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
Home Monitoring
n=977 participants at risk
Home Monitoring programmed ON
Conventional
n=473 participants at risk
Home Monitoring programmed OFF
Surgical and medical procedures
Ablation procedure
0.51%
5/977 • Number of events 5 • 15 Months
Strokes or complications that lead to a surgical intervention were required to be reported. Complications that led to a surgical intervention include but are not limited to a lead revision, cardiac interventional procedure, or device replacement. Other AEs were reported at the discretion of the investigator and may include non-cardiac events.
0.85%
4/473 • Number of events 4 • 15 Months
Strokes or complications that lead to a surgical intervention were required to be reported. Complications that led to a surgical intervention include but are not limited to a lead revision, cardiac interventional procedure, or device replacement. Other AEs were reported at the discretion of the investigator and may include non-cardiac events.
Surgical and medical procedures
Aborted upgrade procedure
0.00%
0/977 • 15 Months
Strokes or complications that lead to a surgical intervention were required to be reported. Complications that led to a surgical intervention include but are not limited to a lead revision, cardiac interventional procedure, or device replacement. Other AEs were reported at the discretion of the investigator and may include non-cardiac events.
0.21%
1/473 • Number of events 1 • 15 Months
Strokes or complications that lead to a surgical intervention were required to be reported. Complications that led to a surgical intervention include but are not limited to a lead revision, cardiac interventional procedure, or device replacement. Other AEs were reported at the discretion of the investigator and may include non-cardiac events.
Cardiac disorders
Cardiac related hospitalizations
4.6%
45/977 • Number of events 64 • 15 Months
Strokes or complications that lead to a surgical intervention were required to be reported. Complications that led to a surgical intervention include but are not limited to a lead revision, cardiac interventional procedure, or device replacement. Other AEs were reported at the discretion of the investigator and may include non-cardiac events.
6.6%
31/473 • Number of events 35 • 15 Months
Strokes or complications that lead to a surgical intervention were required to be reported. Complications that led to a surgical intervention include but are not limited to a lead revision, cardiac interventional procedure, or device replacement. Other AEs were reported at the discretion of the investigator and may include non-cardiac events.
Surgical and medical procedures
Catheterization/PCI procedure
1.5%
15/977 • Number of events 16 • 15 Months
Strokes or complications that lead to a surgical intervention were required to be reported. Complications that led to a surgical intervention include but are not limited to a lead revision, cardiac interventional procedure, or device replacement. Other AEs were reported at the discretion of the investigator and may include non-cardiac events.
0.63%
3/473 • Number of events 4 • 15 Months
Strokes or complications that lead to a surgical intervention were required to be reported. Complications that led to a surgical intervention include but are not limited to a lead revision, cardiac interventional procedure, or device replacement. Other AEs were reported at the discretion of the investigator and may include non-cardiac events.
Surgical and medical procedures
Coronary artery bypass graft procedure
0.31%
3/977 • Number of events 3 • 15 Months
Strokes or complications that lead to a surgical intervention were required to be reported. Complications that led to a surgical intervention include but are not limited to a lead revision, cardiac interventional procedure, or device replacement. Other AEs were reported at the discretion of the investigator and may include non-cardiac events.
0.00%
0/473 • 15 Months
Strokes or complications that lead to a surgical intervention were required to be reported. Complications that led to a surgical intervention include but are not limited to a lead revision, cardiac interventional procedure, or device replacement. Other AEs were reported at the discretion of the investigator and may include non-cardiac events.
General disorders
Death
5.3%
52/977 • Number of events 52 • 15 Months
Strokes or complications that lead to a surgical intervention were required to be reported. Complications that led to a surgical intervention include but are not limited to a lead revision, cardiac interventional procedure, or device replacement. Other AEs were reported at the discretion of the investigator and may include non-cardiac events.
5.5%
26/473 • Number of events 26 • 15 Months
Strokes or complications that lead to a surgical intervention were required to be reported. Complications that led to a surgical intervention include but are not limited to a lead revision, cardiac interventional procedure, or device replacement. Other AEs were reported at the discretion of the investigator and may include non-cardiac events.
Surgical and medical procedures
Device change-out
0.82%
8/977 • Number of events 8 • 15 Months
Strokes or complications that lead to a surgical intervention were required to be reported. Complications that led to a surgical intervention include but are not limited to a lead revision, cardiac interventional procedure, or device replacement. Other AEs were reported at the discretion of the investigator and may include non-cardiac events.
0.63%
3/473 • Number of events 3 • 15 Months
Strokes or complications that lead to a surgical intervention were required to be reported. Complications that led to a surgical intervention include but are not limited to a lead revision, cardiac interventional procedure, or device replacement. Other AEs were reported at the discretion of the investigator and may include non-cardiac events.
Surgical and medical procedures
Device revision
1.7%
17/977 • Number of events 18 • 15 Months
Strokes or complications that lead to a surgical intervention were required to be reported. Complications that led to a surgical intervention include but are not limited to a lead revision, cardiac interventional procedure, or device replacement. Other AEs were reported at the discretion of the investigator and may include non-cardiac events.
1.5%
7/473 • Number of events 7 • 15 Months
Strokes or complications that lead to a surgical intervention were required to be reported. Complications that led to a surgical intervention include but are not limited to a lead revision, cardiac interventional procedure, or device replacement. Other AEs were reported at the discretion of the investigator and may include non-cardiac events.
Surgical and medical procedures
Heart transplant
0.10%
1/977 • Number of events 1 • 15 Months
Strokes or complications that lead to a surgical intervention were required to be reported. Complications that led to a surgical intervention include but are not limited to a lead revision, cardiac interventional procedure, or device replacement. Other AEs were reported at the discretion of the investigator and may include non-cardiac events.
0.00%
0/473 • 15 Months
Strokes or complications that lead to a surgical intervention were required to be reported. Complications that led to a surgical intervention include but are not limited to a lead revision, cardiac interventional procedure, or device replacement. Other AEs were reported at the discretion of the investigator and may include non-cardiac events.
Surgical and medical procedures
IVC filter implanted
0.10%
1/977 • Number of events 1 • 15 Months
Strokes or complications that lead to a surgical intervention were required to be reported. Complications that led to a surgical intervention include but are not limited to a lead revision, cardiac interventional procedure, or device replacement. Other AEs were reported at the discretion of the investigator and may include non-cardiac events.
0.00%
0/473 • 15 Months
Strokes or complications that lead to a surgical intervention were required to be reported. Complications that led to a surgical intervention include but are not limited to a lead revision, cardiac interventional procedure, or device replacement. Other AEs were reported at the discretion of the investigator and may include non-cardiac events.
Surgical and medical procedures
LV assist device implanted
0.10%
1/977 • Number of events 1 • 15 Months
Strokes or complications that lead to a surgical intervention were required to be reported. Complications that led to a surgical intervention include but are not limited to a lead revision, cardiac interventional procedure, or device replacement. Other AEs were reported at the discretion of the investigator and may include non-cardiac events.
0.00%
0/473 • 15 Months
Strokes or complications that lead to a surgical intervention were required to be reported. Complications that led to a surgical intervention include but are not limited to a lead revision, cardiac interventional procedure, or device replacement. Other AEs were reported at the discretion of the investigator and may include non-cardiac events.
Surgical and medical procedures
Lead revision/explant/replacement
1.6%
16/977 • Number of events 16 • 15 Months
Strokes or complications that lead to a surgical intervention were required to be reported. Complications that led to a surgical intervention include but are not limited to a lead revision, cardiac interventional procedure, or device replacement. Other AEs were reported at the discretion of the investigator and may include non-cardiac events.
1.1%
5/473 • Number of events 5 • 15 Months
Strokes or complications that lead to a surgical intervention were required to be reported. Complications that led to a surgical intervention include but are not limited to a lead revision, cardiac interventional procedure, or device replacement. Other AEs were reported at the discretion of the investigator and may include non-cardiac events.
General disorders
Non-cardiac related hospitalizations
1.6%
16/977 • Number of events 20 • 15 Months
Strokes or complications that lead to a surgical intervention were required to be reported. Complications that led to a surgical intervention include but are not limited to a lead revision, cardiac interventional procedure, or device replacement. Other AEs were reported at the discretion of the investigator and may include non-cardiac events.
0.63%
3/473 • Number of events 4 • 15 Months
Strokes or complications that lead to a surgical intervention were required to be reported. Complications that led to a surgical intervention include but are not limited to a lead revision, cardiac interventional procedure, or device replacement. Other AEs were reported at the discretion of the investigator and may include non-cardiac events.
Surgical and medical procedures
Non-cardiac surgical interventions
0.72%
7/977 • Number of events 8 • 15 Months
Strokes or complications that lead to a surgical intervention were required to be reported. Complications that led to a surgical intervention include but are not limited to a lead revision, cardiac interventional procedure, or device replacement. Other AEs were reported at the discretion of the investigator and may include non-cardiac events.
0.63%
3/473 • Number of events 4 • 15 Months
Strokes or complications that lead to a surgical intervention were required to be reported. Complications that led to a surgical intervention include but are not limited to a lead revision, cardiac interventional procedure, or device replacement. Other AEs were reported at the discretion of the investigator and may include non-cardiac events.
Surgical and medical procedures
Permacath for dialysis and endoscopy
0.10%
1/977 • Number of events 1 • 15 Months
Strokes or complications that lead to a surgical intervention were required to be reported. Complications that led to a surgical intervention include but are not limited to a lead revision, cardiac interventional procedure, or device replacement. Other AEs were reported at the discretion of the investigator and may include non-cardiac events.
0.00%
0/473 • 15 Months
Strokes or complications that lead to a surgical intervention were required to be reported. Complications that led to a surgical intervention include but are not limited to a lead revision, cardiac interventional procedure, or device replacement. Other AEs were reported at the discretion of the investigator and may include non-cardiac events.
Surgical and medical procedures
Tighten loose set screw
0.00%
0/977 • 15 Months
Strokes or complications that lead to a surgical intervention were required to be reported. Complications that led to a surgical intervention include but are not limited to a lead revision, cardiac interventional procedure, or device replacement. Other AEs were reported at the discretion of the investigator and may include non-cardiac events.
0.21%
1/473 • Number of events 1 • 15 Months
Strokes or complications that lead to a surgical intervention were required to be reported. Complications that led to a surgical intervention include but are not limited to a lead revision, cardiac interventional procedure, or device replacement. Other AEs were reported at the discretion of the investigator and may include non-cardiac events.

Other adverse events

Adverse event data not reported

Additional Information

Justin Michalski, M.S. / Clinical Studies Engineer

Biotronik, Inc.

Phone: 503-675-2155

Results disclosure agreements

  • Principal investigator is a sponsor employee The investigator agrees to provide copies of any abstracts, papers or manuscripts to the Sponsor for review within a reasonable period prior to submittal for publication. BIOTRONIK limits its review to a determination of whether Confidential Information (CI) is disclosed and may not attempt to censor or in any way interfere with the investigator's presentation or conclusions beyond the extent necessary to protect CI or to allow to protect its rights in patentable or copyrightable material.
  • Publication restrictions are in place

Restriction type: OTHER